Estados financieros detallados de ClearPoint Neuro, Inc. (CLPT): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
ClearPoint Neuro, Inc. registró ingresos de $37.0M en el último ejercicio fiscal, con un CAGR de 5 años del 23.6%.
Márgenes de los últimos 12 meses: margen bruto 62.6%, margen operativo -73.4%, margen neto -81.8%.
Al precio actual de $13.40, CLPT presenta beneficios negativos (P/E no significativo) y un ROE del -188.09%. La capitalización bursátil es de $402M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $5.7M | $7.4M | $7.4M | $11.2M | $12.8M | $16.3M | $20.6M | $24.0M | $31.4M | $37.0M |
| Coste de Ventas | $2.6M | $2.9M | $2.4M | $3.9M | $3.7M | $5.2M | $7.0M | $10.3M | $12.3M | $14.3M |
| Beneficio Bruto | $3.1M | $4.5M | $4.9M | $7.3M | $9.1M | $11.1M | $13.5M | $13.6M | $19.1M | $22.7M |
| I+D | $2.6M | $2.8M | $2.3M | $2.8M | $4.7M | $9.3M | $10.9M | $11.7M | $12.4M | $13.9M |
| Generales y Administrativos | $8.0M | $8.0M | $7.9M | $9.1M | $10.7M | $15.2M | $19.0M | $24.4M | $26.5M | $33.0M |
| Gastos Operativos | $10.6M | $10.8M | $10.2M | $11.9M | $15.3M | $24.5M | $29.9M | $36.1M | $38.9M | $46.9M |
| Beneficio Operativo | -$7.5M | -$6.3M | -$5.2M | -$4.6M | -$6.2M | -$13.4M | -$16.3M | -$22.4M | -$19.7M | -$24.2M |
| EBITDA | -$6.9M | -$6.2M | -$5.1M | -$4.3M | -$4.8M | -$12.7M | -$15.6M | -$20.6M | -$17.0M | -$20.9M |
| Gastos por Intereses | $1.1M | $872926 | $980383 | $955000 | $1.4M | $973000 | $81000 | 0 | 0 | $2.4M |
| Beneficio Antes de Impuestos | -$8.1M | -$7.2M | -$6.2M | -$5.5M | -$6.8M | -$14.4M | -$16.4M | -$22.1M | -$18.9M | -$25.5M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $55000 |
| Beneficio Neto | -$8.1M | -$7.2M | -$6.2M | -$5.5M | -$6.8M | -$14.4M | -$16.4M | -$22.1M | -$18.9M | -$25.5M |
| BPA | $-2.93 | $-0.93 | $-0.56 | $-0.49 | $-0.43 | $-0.69 | $-0.68 | $-0.90 | $-0.70 | $-0.90 |
| BPA Diluido | $-2.93 | $-0.93 | $-0.56 | $-0.49 | $-0.43 | $-0.69 | $-0.68 | $-0.90 | $-0.70 | $-0.90 |
| Acciones en Circulación (Diluidas) | $2.8M | $7.7M | $10.9M | $13.2M | $15.8M | $20.7M | $24.2M | $24.6M | $27.0M | $28.3M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $3.3M | $9.3M | $3.1M | $5.7M | $20.1M | $54.1M | $27.6M | $23.1M | $20.1M | $45.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | $9.9M | 0 | 0 | 0 |
| Cuentas por Cobrar | $865943 | $949415 | $1.2M | $1.1M | $1.9M | $2.3M | $2.7M | $3.9M | $4.7M | $7.3M |
| Inventario | $1.8M | $2.3M | $2.1M | $3.2M | $3.2M | $4.9M | $9.3M | $7.9M | $6.9M | $8.4M |
| Activos Corrientes | $6.1M | $12.7M | $6.7M | $10.4M | $25.5M | $61.9M | $51.2M | $36.2M | $33.4M | $63.6M |
| Inmovilizado Material | $328249 | $267667 | $377706 | $821000 | $3.1M | $2.8M | $2.7M | $5.0M | $5.1M | $11.1M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $7.5M |
| Activos Intangibles | 0 | 0 | 0 | 0 | $353000 | $265000 | $1.0M | $1.0M | $484000 | $13.9M |
| Activos Totales | $7.4M | $13.9M | $7.9M | $11.9M | $29.5M | $65.6M | $55.5M | $42.7M | $39.2M | $97.7M |
| Cuentas por Pagar | $1.5M | $759445 | $500928 | $966000 | $300000 | $427000 | $272000 | $393000 | $1.3M | $1.3M |
| Deuda a Corto | 0 | $2.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $3.0M | $4.4M | $2.0M | $3.8M | $3.2M | $4.8M | $6.8M | $7.4M | $10.4M | $10.8M |
| Deuda a Largo | $4.5M | $2.9M | $3.5M | $2.1M | $21.3M | $9.8M | $9.9M | $9.9M | 0 | $49.1M |
| Pasivos Totales | $8.2M | $8.1M | $6.3M | $7.3M | $27.1M | $16.8M | $18.6M | $21.5M | $13.8M | $69.7M |
| Reservas | -$93.9M | -$101.0M | -$107.2M | -$112.7M | -$119.5M | -$133.9M | -$150.4M | -$172.5M | -$191.4M | -$216.9M |
| Patrimonio Neto | -$756069 | $5.8M | $1.5M | $4.6M | $2.4M | $48.8M | $36.9M | $21.2M | $25.4M | $28.0M |
| Deuda Total | $4.5M | $4.9M | $3.5M | $2.5M | $24.1M | $12.3M | $12.0M | $13.9M | $3.6M | $58.2M |
| Deuda Neta | $1.2M | -$4.4M | $379508 | -$3.2M | $4.0M | -$41.8M | -$25.5M | -$9.2M | -$16.5M | $12.3M |
| Capital Circulante | $3.1M | $8.3M | $4.6M | $6.6M | $22.3M | $57.1M | $44.4M | $28.7M | $23.0M | $52.8M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$8.1M | -$7.2M | -$6.2M | -$5.5M | -$6.8M | -$14.4M | -$16.4M | -$22.1M | -$18.9M | -$25.5M |
| Amortizaciones | $155707 | $116454 | $109439 | $250560 | $553000 | $692000 | $777000 | $1.5M | $1.9M | $982000 |
| Compensación en Acciones | $959585 | $1.2M | $1.2M | $799110 | $1.1M | $2.1M | $4.1M | $6.1M | $6.9M | $8.2M |
| Cambio en Capital Circulante | $672221 | -$1.1M | -$383652 | $911319 | -$2.7M | -$1.7M | -$4.3M | -$1.4M | $1.4M | -$9.8M |
| Flujo de Caja Operativo | -$5.8M | -$6.0M | -$4.6M | -$2.8M | -$7.8M | -$12.7M | -$16.2M | -$13.7M | -$8.9M | -$23.9M |
| Inversiones (CapEx) | -$101002 | -$26752 | -$63490 | -$160190 | -$482000 | -$168000 | -$253000 | -$717000 | -$275000 | -$522000 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $1.1M |
| Recompra de Acciones | -$4756 | 0 | 0 | 0 | 0 | 0 | 0 | -$210000 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$5.9M | -$6.0M | -$4.7M | -$3.0M | -$8.3M | -$12.9M | -$16.4M | -$14.4M | -$9.2M | -$24.4M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +28.4% | -0.4% | +52.5% | +14.4% | +27.0% | +26.1% | +16.6% | +31.0% | +17.8% | |
| Crecimiento Beneficio Neto (anual) | +11.2% | +14.0% | +10.1% | -22.4% | -112.5% | -14.1% | -34.4% | +14.4% | -35.0% | |
| Crecimiento BPA (anual) | +68.3% | +39.8% | +12.5% | +12.2% | -60.5% | +1.4% | -32.4% | +22.2% | -28.6% | |
| Cambio en Acciones (anual) | +180.9% | +41.2% | +20.4% | +20.5% | +30.8% | +16.6% | +1.8% | +9.8% | +4.8% | |
| Crecimiento FCF (anual) | -1.7% | +22.0% | +35.9% | -175.4% | -55.2% | -27.6% | +12.1% | +36.1% | -165.0% | |
| Margen Bruto | 54.0% | 60.7% | 66.9% | 64.9% | 71.1% | 68.2% | 65.8% | 56.8% | 60.9% | 61.4% |
| Margen Operativo | -130.3% | -85.9% | -71.4% | -41.0% | -48.5% | -82.1% | -79.5% | -93.7% | -62.9% | -65.4% |
| Margen EBITDA | -119.2% | -83.7% | -69.0% | -38.6% | -37.3% | -78.2% | -75.8% | -86.1% | -54.2% | -56.4% |
| Margen Neto | -140.4% | -97.1% | -83.8% | -49.4% | -52.9% | -88.4% | -80.0% | -92.2% | -60.3% | -69.1% |
| Margen FCF | -103.0% | -81.6% | -63.8% | -26.8% | -64.6% | -78.9% | -79.9% | -60.3% | -29.4% | -66.1% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.2% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-2.15 | $-0.78 | $-0.43 | $-0.23 | $-0.52 | $-0.62 | $-0.68 | $-0.59 | $-0.34 | $-0.86 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $2.8M | $7.7M | $10.9M | $13.2M | $15.8M | $20.7M | $24.2M | $24.6M | $27.0M | $28.3M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -188.09% |
| Rentabilidad sobre capital invertido | -40.49% |
| Rentabilidad sobre activos | -39.85% |
| Margen bruto | 62.61% |
| Margen operativo | -73.42% |
| Margen neto | -81.76% |
Salud financiera
| Deuda / Patrimonio | 5.93 |
| Ratio corriente | 4.73 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -1.16 | -2.96 | -2.80 | -9.80 | -36.95 | -16.26 | -12.46 | -7.54 | -21.97 | -15.20 |
| P/VC | -12.39 | 3.65 | 11.35 | 13.77 | 105.95 | 4.77 | 5.55 | 7.89 | 16.37 | 13.82 |
| P/V | 1.63 | 2.88 | 2.33 | 5.63 | 19.63 | 14.27 | 9.97 | 6.97 | 13.24 | 10.48 |
| Margen Bruto | 54.0% | 60.7% | 66.9% | 64.9% | 71.1% | 68.2% | 65.8% | 56.8% | 60.9% | 61.4% |
| Margen Operativo | -130.3% | -85.9% | -71.4% | -41.0% | -48.5% | -82.1% | -79.5% | -93.7% | -62.9% | -65.4% |
| Margen Neto | -140.4% | -97.1% | -83.8% | -49.4% | -52.9% | -88.4% | -80.0% | -92.2% | -60.3% | -69.1% |
Empresas relacionadas: AKBA · AVNS · CMPS · CTKB · LAB · OFIX · SIBN
Explorar sector: Healthcare · Medical - Devices
Más secciones de CLPT: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones